SLU-PP-332 — Research Overview

SLU-PP-332 is a novel, selective agonist of the Estrogen-Related Receptor Alpha (ERRα), a nuclear receptor that functions as a master transcriptional regulator of genes involved in energy expenditure, mitochondrial oxidative metabolism, and adaptive thermogenesis. Unlike compounds that influence metabolic pathways indirectly, SLU-PP-332 directly binds to and activates ERRα, triggering downstream upregulation of PGC-1α, PDK4, and components of the electron transport chain and fatty acid oxidation pathways. This mechanism of direct ERRα activation has made it a compound of significant interest in metabolic disease research, exercise science models, and neurological studies focused on cellular bioenergetics. Available from 4-LD in 5mg lyophilized form with optional DMSO solution, SLU-PP-332 is produced under quality-controlled conditions exclusively for qualified researchers and laboratory professionals conducting in-vitro and controlled research applications.

Areas of Active Research

SLU-PP-332 has been studied across several active research areas. In metabolic disease research, diet-induced obese mouse models have examined its effects on glucose tolerance, insulin sensitivity, fat mass reduction, and hepatic lipid accumulation, with findings suggesting its ERRα activation promotes increased energy expenditure and fatty acid oxidation through mechanisms distinct from appetite suppression, making it a relevant tool for non-appetite-based obesity and NAFLD research. In exercise performance and muscle research, preclinical rodent studies have examined its ability to increase maximal running endurance capacity and promote skeletal muscle remodeling from fast-twitch glycolytic fiber types toward slow-twitch oxidative fiber types, with findings documenting significant increases in mitochondrial density within skeletal muscle tissue. In neurological research, studies have examined ERRα activation as a potential neuroprotective mechanism, with preclinical models investigating its effects on neuronal mitochondrial function, protection against amyloid-beta and mutant huntingtin toxicity, and cellular resilience in ischemic brain injury models. In anti-aging and cellular resilience research, studies have explored its potential role in compensating for age-related mitochondrial dysfunction by increasing the pool of functional mitochondria and improving cellular stress resistance. All findings referenced are from preclinical and in-vitro studies. This product is intended solely for laboratory research by qualified professionals and is not for human or animal consumption. 4-LD makes no therapeutic claims regarding this compound.